INTERNATIONAL BIOTECHNOLOGY TRUST PLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$564,705
-24.7%
23,5000.0%0.19%
-16.7%
Q2 2023$750,355
+4.5%
23,5000.0%0.23%
+14.0%
Q1 2023$717,925
-21.9%
23,5000.0%0.20%
-29.6%
Q4 2022$919,085
-17.9%
23,5000.0%0.28%
-20.9%
Q3 2022$1,119,000
-95.2%
23,500
+2482.4%
0.36%
+46.5%
Q2 2022$23,500,0009100.24%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders